Schedule 13G ownership disclosure
Cardiff Oncology Inc
Security class unavailable · CUSIP: 14147L108
Event date: 2020-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-113928
- Form type
- SC 13G
- Filer
- Cardiff Oncology, Inc.
- CIK
- CIK 1213037
- Filed
- Oct 09, 2020
- Reporting period
- Sep 30, 2020
- Description
- Schedule 13G beneficial ownership